Yuhei Kamada
Kagoshima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Validation of prognostic indices in adult T-cell leukemia/lymphoma and their prognostic value at the start of second-line treatment.
Journal: Leukemia & lymphoma
Published: April 01, 2026
Clinical features and incidence of central nervous system involvement in patients with adult T-cell leukaemia/lymphoma.
Journal: British journal of haematology
Published: August 28, 2025
Spontaneous regression of HIV-associated EBV-positive mucocutaneous ulcer due to immune reconstruction with antiretroviral therapy
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: February 04, 2024
Identification of putative noncanonical driver mutations in patients with essential thrombocythemia.
Identification of putative noncanonical driver mutations in patients with essential thrombocythemia.
Journal: European journal of haematology
Published: October 28, 2022
Prediction of the risk for graft versus host disease after allogeneic hematopoietic stem cell transplantation in patients treated with mogamulizumab.
Journal: Leukemia & lymphoma
Published: February 28, 2022
Adult T-cell leukemia-lymphoma with severe hepatic damage and fluid retention successfully treated with mogamulizumab
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: July 07, 2020
RLTPR Q575E: A novel recurrent gain-of-function mutation in patients with adult T-cell leukemia/lymphoma.
Journal: European journal of haematology
Published: June 26, 2020
Essential thrombocytosis attributed to JAK2-T875N germline mutation.
Journal: International journal of hematology
Published: May 26, 2019
Clinical significance of cutaneous adverse reaction to mogamulizumab in relapsed or refractory adult T-cell leukaemia-lymphoma.
Journal: British journal of haematology
Published: April 04, 2017
Clinical significance of CD70 expression on T cells in human T-lymphotropic virus type-1 carriers and adult T cell leukemia/ lymphoma patients.
Journal: Leukemia & lymphoma
Published: June 17, 2015
A new ATL xenograft model and evaluation of pyrrolidine dithiocarbamate as a potential ATL therapeutic agent.
Journal: Experimental hematology
Published: December 31, 2014
A retrospective analysis of treatment outcomes in adult T cell leukemia/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: A single-center experience.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: September 25, 2014
Last Updated: 09/26/2026